India faces a rising burden of blood cancers, with around 120,000 new cases and over 70,000 deaths annually from leukemia, ...

Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...

India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...

Explore the journey of Georgie Swallow who was diagnosed with Stage 4 Hodgkin Lymphoma after ignoring symptoms Read ahead to ...

Immuneel Therapeutics introduces Qartemi, India's first personalised CAR T-cell therapy for B-NHL, offering affordable ...

Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST] ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

Lymphoma, a cancer of the lymphatic system, is grouped into two major types—Hodgkin’s and non-Hodgkin’s. Hodgkin’s lymphoma is a B-cell lymphoma. Non-Hodgkin’s lymphoma is further ...

Exposure to the weedkiller Roundup (glyphosate) has been linked to an increased risk of non-Hodgkin's lymphoma.

Lymphoma is a cancer of the lymphatic system, with two major types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Rashes in HL aren’t very common but can occur as a symptom of the ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...